Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vidaud

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Journal of Viral Hepatitis|October 15, 2013
IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patientsQ Zhang, M Lapalus, T Asselah, et al.
Gut|August 13, 2009
Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4R Moucari, M-P Ripault, M Martinot-Peignoux, et al.
Journal of Medical Genetics|April 16, 2009
SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotypeE Pasmant, A Sabbagh, N Hanna, et al.
Journal of Viral Hepatitis|December 22, 1999
A short induction regimen of interferon-alpha is not effective for treatment of relapse in chronic hepatitis C: a randomized trial. For the multicentre GER-CYT-01 groupT Poynard, V Daurat, S Chevret, et al.
Blood|September 15, 1995
Factor VIII gene inversions in severe hemophilia A: results of an international consortium studyS E Antonarakis, J P Rossiter, M Young, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Journal of Viral Hepatitis|October 15, 2013
IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patientsQ Zhang, M Lapalus, T Asselah, et al.
Gut|August 13, 2009
Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4R Moucari, M-P Ripault, M Martinot-Peignoux, et al.
Journal of Medical Genetics|April 16, 2009
SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotypeE Pasmant, A Sabbagh, N Hanna, et al.
Journal of Viral Hepatitis|December 22, 1999
A short induction regimen of interferon-alpha is not effective for treatment of relapse in chronic hepatitis C: a randomized trial. For the multicentre GER-CYT-01 groupT Poynard, V Daurat, S Chevret, et al.
Blood|September 15, 1995
Factor VIII gene inversions in severe hemophilia A: results of an international consortium studyS E Antonarakis, J P Rossiter, M Young, et al.
Pageof 14